[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1041689B - ((氨基亞氨基甲基)氨基)鏈烷羧酰胺及其在治療中的應用 - Google Patents

((氨基亞氨基甲基)氨基)鏈烷羧酰胺及其在治療中的應用

Info

Publication number
HK1041689B
HK1041689B HK02103446.2A HK02103446A HK1041689B HK 1041689 B HK1041689 B HK 1041689B HK 02103446 A HK02103446 A HK 02103446A HK 1041689 B HK1041689 B HK 1041689B
Authority
HK
Hong Kong
Prior art keywords
alkanecarboxamides
aminoiminomethyl
therapy
amino
applications
Prior art date
Application number
HK02103446.2A
Other languages
English (en)
Other versions
HK1041689A1 (en
Inventor
G‧莫耐特
D‧克拉沃
D‧梅桑吉奧
L‧多爾
M‧克高特
Original Assignee
默克專利股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 默克專利股份有限公司 filed Critical 默克專利股份有限公司
Publication of HK1041689A1 publication Critical patent/HK1041689A1/xx
Publication of HK1041689B publication Critical patent/HK1041689B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/04—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C279/14—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02103446.2A 1999-01-11 2002-05-07 ((氨基亞氨基甲基)氨基)鏈烷羧酰胺及其在治療中的應用 HK1041689B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9900194A FR2788275B1 (fr) 1999-01-11 1999-01-11 ((aminoiminomethyl)amino) alcane carboxamides et leurs applications en therapeutique
PCT/EP1999/010468 WO2000042001A1 (en) 1999-01-11 1999-12-30 ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy

Publications (2)

Publication Number Publication Date
HK1041689A1 HK1041689A1 (en) 2002-07-19
HK1041689B true HK1041689B (zh) 2005-09-02

Family

ID=9540749

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02103446.2A HK1041689B (zh) 1999-01-11 2002-05-07 ((氨基亞氨基甲基)氨基)鏈烷羧酰胺及其在治療中的應用

Country Status (27)

Country Link
US (1) US6518458B1 (zh)
EP (1) EP1140803B1 (zh)
JP (1) JP4567889B2 (zh)
KR (1) KR100630291B1 (zh)
CN (1) CN1182109C (zh)
AR (1) AR022221A1 (zh)
AT (1) ATE252553T1 (zh)
AU (1) AU760147B2 (zh)
BR (1) BR9916858A (zh)
CA (1) CA2359454C (zh)
CZ (1) CZ20012482A3 (zh)
DE (1) DE69912315T2 (zh)
DK (1) DK1140803T3 (zh)
EE (1) EE200100363A (zh)
ES (1) ES2207325T3 (zh)
FR (1) FR2788275B1 (zh)
HK (1) HK1041689B (zh)
HU (1) HUP0200023A3 (zh)
ID (1) ID29586A (zh)
IL (1) IL144225A0 (zh)
NO (1) NO20013420L (zh)
NZ (1) NZ513467A (zh)
PT (1) PT1140803E (zh)
RU (1) RU2236401C2 (zh)
SK (1) SK285130B6 (zh)
WO (1) WO2000042001A1 (zh)
ZA (1) ZA200106606B (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005105152A2 (en) 2004-05-05 2005-11-10 Atugen Ag Lipids, lipid complexes and use thereof
CN101287497B (zh) 2004-12-27 2013-03-06 赛伦斯治疗公司 涂层脂质复合体和它们的用途
TW200808705A (en) * 2006-06-15 2008-02-16 Sanofi Aventis Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
EP2049658A2 (en) * 2006-07-21 2009-04-22 Silence Therapeutics AG Means for inhibiting the expression of protein kinase 3
US8350077B2 (en) * 2008-12-24 2013-01-08 Vertex Closed Joint Stock Company Amides of creatine, method of their preparation, and remedy possessing a neuroprotective activity

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1153424A (en) * 1965-04-15 1969-05-29 Horlicks Ltd Pharmaceutical Compositions
US5654451B1 (en) * 1993-01-14 2000-02-22 Magainin Pharma Amino acids and peptides having modified c-terminals and modified n-terminals
JPH0841008A (ja) * 1994-07-29 1996-02-13 Ono Pharmaceut Co Ltd 一酸化窒素合成酵素阻害剤
CA2217550A1 (en) * 1996-10-22 1998-04-22 F. Hoffmann-La Roche Ag Cationic lipids for gene therapy
US6395713B1 (en) * 1997-07-23 2002-05-28 Ribozyme Pharmaceuticals, Inc. Compositions for the delivery of negatively charged molecules
DE19748697A1 (de) * 1997-11-04 1999-05-06 Basf Ag Verfahren zur Herstellung von substituierten Guanidinderivaten

Also Published As

Publication number Publication date
DE69912315D1 (de) 2003-11-27
SK9842001A3 (en) 2001-12-03
AU760147B2 (en) 2003-05-08
JP2002534496A (ja) 2002-10-15
IL144225A0 (en) 2002-05-23
JP4567889B2 (ja) 2010-10-20
CN1333747A (zh) 2002-01-30
KR100630291B1 (ko) 2006-09-29
EE200100363A (et) 2002-10-15
CZ20012482A3 (cs) 2001-10-17
EP1140803A1 (en) 2001-10-10
HUP0200023A3 (en) 2003-04-28
EP1140803B1 (en) 2003-10-22
NO20013420D0 (no) 2001-07-10
US6518458B1 (en) 2003-02-11
ZA200106606B (en) 2002-11-11
CA2359454A1 (en) 2000-07-20
PT1140803E (pt) 2004-03-31
CN1182109C (zh) 2004-12-29
SK285130B6 (sk) 2006-07-07
FR2788275B1 (fr) 2002-06-14
HUP0200023A2 (hu) 2002-05-29
AU3044300A (en) 2000-08-01
ES2207325T3 (es) 2004-05-16
NZ513467A (en) 2003-08-29
FR2788275A1 (fr) 2000-07-13
HK1041689A1 (en) 2002-07-19
AR022221A1 (es) 2002-09-04
KR20010089822A (ko) 2001-10-08
ATE252553T1 (de) 2003-11-15
RU2236401C2 (ru) 2004-09-20
DE69912315T2 (de) 2004-08-05
CA2359454C (en) 2009-10-27
BR9916858A (pt) 2001-12-04
DK1140803T3 (da) 2003-12-22
NO20013420L (no) 2001-07-10
ID29586A (id) 2001-09-06
WO2000042001A1 (en) 2000-07-20

Similar Documents

Publication Publication Date Title
HUP0301003A3 (en) Casein derived peptides and uses thereof in therapy
AU7925501A (en) Composite elastic in one direction and extensible in another direction
HUP0400069A3 (en) Pharmaceutical combinations and their use in preventing and treating the thrombosis
GB9806806D0 (en) Peptides and uses thereof
SI1462455T1 (sl) Ser-Ser-Ser-Arg Peptid in zdravilna uporaba le-tega
EP1414848A4 (en) REPLICINE PEPTIDES AND ITS USES
AU2001266229A1 (en) Hcn polypeptides and polynucleotides and their use in therapy
IL160548A0 (en) Casein derived peptides and uses thereof in therapy
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
IL144225A0 (en) ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
GB0026134D0 (en) Peptides and their use
ZA983740B (en) Novel amidine derivatives and their use in therapy
SI1140803T1 (en) ((aminoiminomethyl) amino) alkanecarboxamides and their applications in therapy
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
IL151351A0 (en) Casein derived peptides and uses thereof in therapy
GB0017028D0 (en) Peptides and their therapeutic use
SG2012018057A (en) Replikin peptides and uses thereof
SI1177312T1 (sl) Humani gil-19/ae289 proteini in polinukleotidi, ki omenjene kodirajo
GB0026135D0 (en) Peptides and their use
GB0018148D0 (en) Peptides and their use
GB0026136D0 (en) Peptides and their use
AU2002216883A1 (en) The polyester containing active drugs and having amino acids in the main chain, and its preparation method
HK1041930A1 (en) Polmers contain tetrahydrofurfuryl oxycarbonyl group and be used in photoresist application
GB0125955D0 (en) Improvements in financial administration systems and methods
GB0019503D0 (en) Proteins and their uses

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20091230